BioMara targets gut health with fucoidan production scale up

BioMara targets gut health with fucoidan production scale up

Scottish seaweed biotechnology company BioMara has scaled up production of its proprietary fucoidan ingredient, Thalivra, a brown-seaweed derived ingredient. The ingredient will be validated in a three stage clinical trial in collaboration with Abertay University which will investigate Thalivra’s impact on human gut bacteria, specifically looking for increased production of beneficial short-chain fatty acids, a strong indicator of potential gut h